Janak Rashme de Zoysa1,2. 1. Department of Renal Medicine, North Shore Hospital, Waitemata District Health Board, 122 Shakespeare Road, Takapuna, Auckland, 0740, New Zealand. janak.dezoysa@waitematadhb.govt.nz. 2. Faculty of Medicine and Health Sciences, The University of Auckland, Auckland, New Zealand. janak.dezoysa@waitematadhb.govt.nz.
Abstract
BACKGROUND: The Asia Pacific Meeting for Vasculitis and ANCA Workshop was held in Tokyo in May 2012. This review of vasculitis in New Zealand (NZ) was prepared for the meeting. METHODS: A review of significant NZ demographic and health data is presented with information from relevant studies on vasculitis originating from NZ. RESULTS: Giant cell arteritis occurs in older adults, and has an annual incidence of 12.7/100,000 adults over the age of 50 years in NZ. Kawasaki disease, a rare cause of acquired cardiac disease primarily affecting young children, has an annual incidence of 8.0/100,000 children aged less than 5 years. The prevalence of granulomatosis with polyangiitis varies within NZ, with a 5-year prevalence varying from 29 to 75 cases per million people. Dual anti-glomerular basement membrane disease and ANCA-associated systemic vasculitis is rare, with an annual incidence estimated at 0.47 cases per million people. CONCLUSIONS: Vasculitis is an uncommon but a significant cause of morbidity and mortality in NZ.
BACKGROUND: The Asia Pacific Meeting for Vasculitis and ANCA Workshop was held in Tokyo in May 2012. This review of vasculitis in New Zealand (NZ) was prepared for the meeting. METHODS: A review of significant NZ demographic and health data is presented with information from relevant studies on vasculitis originating from NZ. RESULTS: Giant cell arteritis occurs in older adults, and has an annual incidence of 12.7/100,000 adults over the age of 50 years in NZ. Kawasaki disease, a rare cause of acquired cardiac disease primarily affecting young children, has an annual incidence of 8.0/100,000 children aged less than 5 years. The prevalence of granulomatosis with polyangiitis varies within NZ, with a 5-year prevalence varying from 29 to 75 cases per million people. Dual anti-glomerular basement membrane disease and ANCA-associated systemic vasculitis is rare, with an annual incidence estimated at 0.47 cases per million people. CONCLUSIONS:Vasculitis is an uncommon but a significant cause of morbidity and mortality in NZ.